Elise M. A. Slob

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Jurjan Aman, Erik Duijvelaar, Liza Botros et al. · The Lancet Respiratory Medicine · 2021 · 122 citations · Full text

Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study

Elise M. A. Slob, Bronwyn K. Brew, Susanne J. H. Vijverberg et al. · European Respiratory Journal · 2020 · 51 citations · Full text

Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study

Elise M. A. Slob, Bronwyn K. Brew, Susanne J. H. Vijverberg et al. · International Journal of Epidemiology · 2020 · 43 citations · Full text

Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources

T. B. Y. Liem, Elise M. A. Slob, J. Termote et al. · International Journal of Clinical Pharmacy · 2018 · 22 citations · Full text

Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients

Elise M. A. Slob, Rob Shulman, Mervyn Singer · Journal of Critical Care · 2017 · 13 citations

Critical Care Medicine, Electrolyte Disorder, High-dose Glucose-insulin-potassium +4